Nanotechnology revolution in diagnosing and treating urinary tract infections

Urinary tract infections (UTIs) are among the most common bacterial infections worldwide, affecting millions annually and imposing significant healthcare costs. Rising antibiotic resistance among uropathogens coupled with the limitations of culture-based diagnostics and systemic therapies demands innovative approaches. Nanotechnology offers transformative potential, enabling rapid, point of care (POC) detection and targeted antimicrobial interventions that promise to outperform evolving resistance mechanisms.